Overview

A Study Comparing Etoricoxib and Diclofenac Sodium in Post Hallux Valgus Surgery Pain

Status:
Withdrawn
Trial end date:
2010-12-12
Target enrollment:
Participant gender:
Summary
The investigators hypothesize that cyclooxygenas-II-selective inhibitors (Coxibs) provide a better patients assessed overall satisfaction when used for pain management after elective hallux valgus surgery as compared to traditional Non-steroidal anti-inflammatory drugs (NSAIDs).
Phase:
Phase 4
Details
Lead Sponsor:
Karolinska Institutet
Treatments:
Diclofenac
Etoricoxib